Neon Therapeutics

Neon Therapeutics Overview

Founded 2013
Founded
Status Acquired/​Merged
Employees 71
Employees
Latest Deal Type M&A
Latest Deal Amount $67M
Latest Deal Amount
Investors 4

Neon Therapeutics General Information

Description

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 40 Erie Street
  • Suite 110
  • Cambridge, MA 02139
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2020 $67M 00000 0000 Completed Generating Revenue
3. IPO 27-Jun-2018 00000 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Dec-2017 $106M $161M 00000 Completed Startup
1. Early Stage VC (Series A) 01-Oct-2015 $55M $55M 0000 Completed Startup

Neon Therapeutics Cap Table

To view Neon Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000

Neon Therapeutics Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
UNUM Therapeutics Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000 00000000000 Corporation PA 000 000.00 00000000 000.00

Neon Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Hugh O'Dowd Chief Executive Officer & Board Member
Richard Gaynor President
Yasir Al-Wakeel Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Robert Ang MD Executive

11 Former Executives

Neon Therapeutics Board Members (9)

To view Neon Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Cary Pfeffer MD Third Rock Ventures Chairman & Board Member 000 0000
Hugh O'Dowd Neon Therapeutics Chief Executive Officer & Board Member 000 0000
Robert Bazemore Self Board Member 000 0000
Robert Kamen Ph.D Third Rock Ventures Board Member 000 0000
Robert Tepper MD Third Rock Ventures Board Member 000 0000

3 Former Board Members

Neon Therapeutics Former Investors (9)

To view Neon Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ArrowMark Partners Asset Manager Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Clal Biotechnology Industries Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
Inbio Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial